1. [P4–014]: THE COALITION AGAINST MAJOR DISEASES: TOWARD U.S. FDA QUALIFICATION OF HIPPOCAMPAL VOLUME AS A BIOMARKER FOR ENRICHMENT IN CLINICAL TRIALS FOR PRE‐DEMENTIA STAGES OF ALZHEIMER'S DISEASE. (1st July 2017) Authors: Conrado, Daniela J.; Romero, Klaus; Corrigan, Brian; Ito, Kaori; Nicholas, Timothy; Chen, Danny; Samtani, Mahesh N.; Stone, Julie; Sinha, Vikram; Willis, Brian A.; Kern, Volker D.; Hill, Derek L.; Cole, Patricia E.; Novak, Gerald P.; Meibach, Richard; Matthews, Dawn C.; Schwarz, Adam J.; Xie, Zhi... Journal: Alzheimer's & dementia Issue: Volume 13:Supplement 7S(2017)Part 26 Page Start: P1259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Accelerating drug development for Alzheimer's disease through the use of data standards. Issue 2 (15th April 2017) Authors: Neville, Jon; Kopko, Steve; Romero, Klaus; Corrigan, Brian; Stafford, Bob; LeRoy, Elizabeth; Broadbent, Steve; Cisneroz, Martin; Wilson, Ethan; Reiman, Eric; Vanderstichele, Hugo; Arnerić, Stephen P.; Stephenson, Diane Journal: Alzheimer's & dementia Issue: Volume 3:Issue 2(2017) Page Start: 273 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Alzheimer's disease assessment scale‐cognitive 11‐item progression model in mild‐to‐moderate Alzheimer's disease trials of bapineuzumab. Issue 3 (5th October 2015) Authors: Samtani, Mahesh N.; Xu, Steven X.; Russu, Alberto; Adedokun, Omoniyi J.; Lu, Ming; Ito, Kaori; Corrigan, Brian; Raje, Sangeeta; Brashear, H. Robert; Styren, Scot; Hu, Chuanpu Journal: Alzheimer's & dementia Issue: Volume 1:Issue 3(2015) Page Start: 157 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Alzheimer's disease progression model using disability assessment for dementia scores from bapineuzumab trials. Issue 2 (21st July 2015) Authors: Xu, Steven X.; Samtani, Mahesh N.; Russu, Alberto; Adedokun, Omoniyi J.; Lu, Ming; Ito, Kaori; Corrigan, Brian; Raje, Sangeeta; Brashear, H. Robert; Styren, Scot; Hu, Chuanpu Journal: Alzheimer's & dementia Issue: Volume 1:Issue 2(2015) Page Start: 141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data. Issue 4 (11th March 2020) Authors: Conrado, Daniela J.; Duvvuri, Sridhar; Geerts, Hugo; Burton, Jackson; Biesdorf, Carla; Ahamadi, Malidi; Macha, Sreeraj; Hather, Gregory; Francisco Morales, Juan; Podichetty, Jagdeep; Nicholas, Timothy; Stephenson, Diane; Trame, Mirjam; Romero, Klaus; Corrigan, Brian Journal: Clinical pharmacology & therapeutics Issue: Volume 107:Issue 4(2020) Page Start: 796 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis. Issue 1 (27th July 2017) Authors: Conrado, Daniela J.; Nicholas, Timothy; Tsai, Kuenhi; Macha, Sreeraj; Sinha, Vikram; Stone, Julie; Corrigan, Brian; Bani, Massimo; Muglia, Pierandrea; Watson, Ian A.; Kern, Volker D.; Sheveleva, Elena; Marek, Kenneth; Stephenson, Diane T.; Romero, Klaus Journal: Clinical and translational science Issue: Volume 11:Issue 1(2018) Page Start: 63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P1–346: Disease progression modeling of bapineuzumab utilizing Alzheimer's Disability Assessment for Dementia scores. (1st July 2013) Authors: Samtani, Mahesh; Xu, Steven; Adedokun, O.J.; Ito, Kaori; Corrigan, Brian; Raje, Sangeeta; Brashear, Robert H.; Styren, Scot; Hu, Chuanpu; Lu, Ming Journal: Alzheimer's & dementia Issue: Volume 9:Supplement 4S(2013)Part 7 Page Start: P284 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Pharmacokinetics of Oral Nirmatrelvir/Ritonavir, a Protease Inhibitor for Treatment of COVID‐19, in Subjects With Renal Impairment. Issue 4 (5th July 2022) Authors: Toussi, Sima S.; Neutel, Joel Michael; Navarro, Jesus; Preston, Richard Alfred; Shi, Haihong; Kavetska, Olga; LaBadie, Robert R.; Binks, Michael; Chan, Phylinda L.S.; Demers, Neil; Corrigan, Brian; Damle, Bharat Journal: Clinical pharmacology & therapeutics Issue: Volume 112:Issue 4(2022) Page Start: 892 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S3‐02‐01: Quantifying the placebo effect through modeling and simulation. (1st July 2015) Authors: Romero, Klaus; Ito, Kaori; Corrigan, Brian; Anziano, Richard J.; Neville, Jon; Stephenson, Diane; Lalonde, Richard Journal: Alzheimer's & dementia Issue: Volume 11(2015)Supplement 7:Part 4 Page Start: P210 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Serials Spoken Here. Issue 1 (3rd April 2022) Authors: Dawson, Jill; Dennis, Sarah; Colquitt, Michelle; Corrigan, Brian; Shank, Jonathan; Thornton, Bonnie Journal: Serials review Issue: Volume 48:Issue 1/2(2022) Page Start: 181 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗